Abstract
Myocardial constitutive No production depends on the activity of both endothelial and neuronal NOS (eNOS and nNOS, respectively). Stimulation of myocardial β(3)-adrenergic receptor (β(3)-AR) produces a negative inotropic effect that is dependent on eNOS. We evaluated whether nNOS also plays a role in β(3)-AR signaling and found that the β(3)-AR-mediated reduction in cell shortening and [Ca(2+)](i) transient amplitude was abolished both in eNOS(-/-) and nNOS(-/-) left ventricular (LV) myocytes and in wild type LV myocytes after nNOS inhibition with S-methyl-L-thiocitrulline. LV superoxide (O(2)(·-)) production was increased in nNOS(-/-) mice and reduced by L-N(ω)-nitroarginine methyl ester (L-NAME), indicating uncoupling of eNOS activity. eNOS S-glutathionylation and Ser-1177 phosphorylation were significantly increased in nNOS(-/-) myocytes, whereas myocardial tetrahydrobiopterin, eNOS Thr-495 phosphorylation, and arginase activity did not differ between genotypes. Although inhibitors of xanthine oxidoreductase (XOR) or NOX2 NADPH oxidase caused a similar reduction in myocardial O(2)(·-), only XOR inhibition reduced eNOS S-glutathionylation and Ser-1177 phosphorylation and restored both eNOS coupled activity and the negative inotropic and [Ca(2+)](i) transient response to β(3)-AR stimulation in nNOS(-/-) mice. In summary, our data show that increased O(2)(·-) production by XOR selectively uncouples eNOS activity and abolishes the negative inotropic effect of β(3)-AR stimulation in nNOS(-/-) myocytes. These findings provide unequivocal evidence of a functional interaction between the myocardial constitutive NOS isoforms and indicate that aspects of the myocardial phenotype of nNOS(-/-) mice result from disruption of eNOS signaling.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Arginase / genetics
-
Arginase / metabolism
-
Calcium Signaling / drug effects
-
Calcium Signaling / physiology*
-
Citrulline / analogs & derivatives
-
Citrulline / pharmacology
-
Enzyme Inhibitors / pharmacology
-
Heart Ventricles / cytology
-
Heart Ventricles / enzymology
-
Isoenzymes / antagonists & inhibitors
-
Isoenzymes / genetics
-
Isoenzymes / metabolism
-
Membrane Glycoproteins / genetics
-
Membrane Glycoproteins / metabolism
-
Mice
-
Mice, Knockout
-
Muscle Proteins / antagonists & inhibitors
-
Muscle Proteins / genetics
-
Muscle Proteins / metabolism*
-
Myocardium / cytology
-
Myocardium / enzymology*
-
Myocytes, Cardiac / cytology
-
Myocytes, Cardiac / enzymology*
-
NADPH Oxidase 2
-
NADPH Oxidases / genetics
-
NADPH Oxidases / metabolism
-
NG-Nitroarginine Methyl Ester / pharmacology
-
Nitric Oxide Synthase Type I / antagonists & inhibitors
-
Nitric Oxide Synthase Type I / genetics
-
Nitric Oxide Synthase Type I / metabolism*
-
Nitric Oxide Synthase Type III / antagonists & inhibitors
-
Nitric Oxide Synthase Type III / genetics
-
Nitric Oxide Synthase Type III / metabolism*
-
Phosphorylation / drug effects
-
Phosphorylation / physiology
-
Receptors, Adrenergic, beta-3 / genetics
-
Receptors, Adrenergic, beta-3 / immunology
-
Superoxides / metabolism
-
Thiourea / analogs & derivatives
-
Thiourea / pharmacology
-
Xanthine Dehydrogenase / genetics
-
Xanthine Dehydrogenase / metabolism
Substances
-
Enzyme Inhibitors
-
Isoenzymes
-
Membrane Glycoproteins
-
Muscle Proteins
-
Receptors, Adrenergic, beta-3
-
Superoxides
-
Citrulline
-
Nitric Oxide Synthase Type I
-
Nitric Oxide Synthase Type III
-
Nos1 protein, mouse
-
Nos3 protein, mouse
-
Xanthine Dehydrogenase
-
Cybb protein, mouse
-
NADPH Oxidase 2
-
NADPH Oxidases
-
Arginase
-
Thiourea
-
S-methylthiocitrulline
-
NG-Nitroarginine Methyl Ester